Down 65%, Is Viking Therapeutics Stock a Buy on the Dip?
Viking Therapeutics (NASDAQ: VKTX) shares exploded higher after the clinical-stage drugmaker announced successful results ...
Hosted on MSN17h
The battle over anti-obesity medications
Rocketing demand, legal disputes, and the future of weight loss were all spurred by a new class of anti-obesity medications.